FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
MediPal Holdings Corporation Stock AnalysisComprehensive stock analysis for MediPal Holdings Corporation (MAHLY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMAHLY
MAHLY
MediPal Holdings Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MAHLY
Home🔹Stocks🔹MediPal Holdings Corporation

MediPal Holdings Corporation

🇺🇸MAHLY•OTC

MediPal Holdings Corporation

🇺🇸MAHLY•OTC
Market cap
$4.17B
Sentiment

Your view on MAHLY

Mkt Cap
$4.17B
Sentiment
Your view
MAHLY
MediPal Holdings Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MAHLY
Company Overview

Overview

What the company does, where it operates, and who runs it.

About MediPal Holdings Corporation

Industry
Medical - Distribution
Sector
Healthcare
CEO
Shuichi Watanabe
Headquarters
2-7-15, Yaesu, Tokyo, JP
Industry
Medical - Distribution
Sector
Healthcare
CEO
Shuichi Watanabe
Headquarters
2-7-15, Yaesu, Tokyo, JP
Description

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan.

It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products.

The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products.

In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand.

Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers.

The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for MediPal Holdings Corporation, and the rating behind it. MAHLY last traded at $20.35, 12.7× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for MediPal Holdings Corporation. Starting points for MediPal Holdings Corporation: P/E 12.7, EPS $227.62, beta 0.07 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for MediPal Holdings Corporation. MediPal Holdings Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for MediPal Holdings Corporation. Trailing twelve-month EPS for MediPal Holdings Corporation stands at $227.62. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for MediPal Holdings Corporation. MediPal Holdings Corporation has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

MediPal Holdings Corporation valued side by side against its closest peers. MediPal Holdings Corporation is measured against Medical - Distribution peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold MediPal Holdings Corporation, and how their positions are changing. At a $4.17B market value, institutional positions materially move MediPal Holdings Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by MediPal Holdings Corporation executives and directors. Shares of MediPal Holdings Corporation have traded between $14.08 and $20.35 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming MediPal Holdings Corporation. MediPal Holdings Corporation is a $4.17B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming MediPal Holdings Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for MediPal Holdings Corporation. Coverage tracks MediPal Holdings Corporation within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ALFRY — Alfresa Holdings Corporation
  • ANSLF — Ansell Limited
  • ANSLY — Ansell Limited
  • RGEDF — Gedeon Richter PLC
  • RHCGF — Ryman Healthcare Limited
  • SDGCF — Sundrug Co.,Ltd.
  • SHWGF — Shandong Weigao Group Medical Polymer Company Limited
  • SHWGY — Shandong Weigao Group Medical Polymer Company Limited

More Medical - Distribution companies

  • SCRCQ — ScripsAmerica, Inc.
  • SECI — Sector 10, Inc.
  • SHPMF — Shanghai Pharmaceuticals Holding Co., Ltd
  • SHPMY — Shanghai Pharmaceuticals Holding Co., Ltd
  • SHPPF — Redcare Pharmacy N.V.
  • SHTDF — Sinopharm Group Co. Ltd.
  • SHTDY — Sinopharm Group Co. Ltd.
  • SIG.AX — Sigma Healthcare Limited
  • SNYR — Synergy CHC Corp.
  • SZUKF — Suzuken Co., Ltd.
  • YI — 111, Inc.
  • ZHYBF — Zhong Yuan Bio-Technology Holdings Limited

News

Latest Market News